Skip to main content

more options


Physician: Robert J. Kaner, M.D.

Dr. Robert J. Kaner

New York-Presbyterian Hospital/The Weill Medical College of Cornell University
Division of Pulmonary and Critical Care Medicine

520 East 70th Street
Starr Building, Suite 505
New York, NY 10021
phone: 212-746-2250
fax: 603-954-7735

Education:
M.D.  University of Pennsylvania, Philadelphia, PA
B.A.  Brandeis University, Waltham, MA

Post-doctoral Training:
Internship: Hospital of the University of Pennsylvania,
  Philadelphia, PA

Residency: Hospital of the University of Pennsylvania,
  Philadelphia, PA

Fellowship: Pulmonary and Critical Care Medicine, Hospital of
 the University of Pennsylvania, Philadelphia, PA

Fellowship (research): Connective Tissue Research Institute,
  University of Pennsylvania, Philadelphia, PA

Academic Positions:
Associate Professor of Clinical Medicine Division of Pulmonary
 and Critical Care Medicine, Department of Medicine, Weill
 Medical College of Cornell University, New York, NY

Assistant Professor of Medicine, Division of Pulmonary and
 Critical Care Medicine, Weill Medical College of Cornell
  University, New York, NY

Hospital Appointments:
Director, Ventilator Management Team, New York-Presbyterian
  Hospital/Weill Cornell Campus, New York, NY

Associate Attending Physician, New York-Presbyterian
 Hospital/Weill Cornell Campus, New York, NY

Board Certifications:
Internal Medicine (1985)

Pulmonary Medicine (1988)

Critical Care Medicine (1991)

Honors and Awards:
Alpha Omega Alpha, University of Pennsylvania School of
 Medicine (1981)

Dalsemar Research Scholar Award: American Lung Association
 (1989)

Clinical Investigator Development Award: National Institutes of
 Health (1994)

Service Excellence Award, New York Presbyterian Hospital
 (2002)

Principal Investigator, Idiopathic Pulmonary Fibrosis Clinical
 Research Network: National Institutes of Health (2005)

Grants:

Scientific Publications:
  • Stover DE and Kaner RJ. Pulmonary Toxicity in DeVita VT, Hellman S and Rosenberg SA eds): Cancer Principles and Practice of Oncology, 7th Edition, J.P. Lippincott. 2535-2545, 2005.
  • Kaner RJ. Pulmonary Complications of Allogeneic Bone Marrow Transplantation.Pulmonary Up-To-Date Series on CD, 1996-2005..
  • Kaner RJ, Worgall S, Leoold PL, Stolze E, Milano E, Hidaka C, Ramalingam R, Hackett NR, Singh R, Bergelson J, Finberg R, Falck-Pedersen E, and Crystal RG. Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie /adenovirus receptor. Am J Respir Cell Mol Biol, 1999; Mar 1;20(3):361-370.
  • Kaner RJ, Ladetto J, Singh R, Fukuda N, Matthay M and Crystal RG. Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema. Am J Respir Cell Mol Biol 22:657-664, 2000.
  • Kaner RJ and Crystal RG. Compartmentalization of vascular endothelial growth factor to the epithelial surface of the human lung. Molecular Medicine, April 2001; 7(4):240-246.
  • Kaner RJ, Crystal RG. Pathogenesis of high altitude pulmonary edema: does alveolar epithelial lining fluid vascular endothelial growth factor exacerbate capillary leak? High Alt Med Biol. 2004;5(4):399-409.